Literature DB >> 26053648

FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care.

E Hillebrenner1, E Litwack1, P Bradley1, K Donigan1, T Lowe1, K Serrano1, K Kelm1, E Mansfield1, A Gutierrez1.   

Abstract

Mesh：

Year:  2015        PMID： 26053648     DOI： 10.1002/jcph.521

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  2 in total

1.  Identifying End Users' Preferences about Structuring Pharmacogenetic Test Orders in an Electronic Health Record System.

Authors:  Leland E Hull; Jason L Vassy; Annjanette Stone; Catherine C Chanfreau-Coffinier; Craig W Heise; Victoria M Pratt; Ronald Przygodzki; Corrine I Voils; Deepak Voora; Jessica Wang-Rodriguez; Steven A Schichman; Maren T Scheuner
Journal:  J Mol Diagn       Date:  2020-10       Impact factor: 5.568

2.  Integrating pharmacogenetic testing into primary care.

Authors:  Susanne B Haga
Journal:  Expert Rev Precis Med Drug Dev       Date:  2017-11-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.